Elna Osso

Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial

Gustavo E. Velásquez, Meredith B. Brooks, Julia Coit et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 113 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort

Catherine Hewison, Uzma Khan, Mathieu Bastard et al. · Clinical Infectious Diseases · 2022 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis

Charles A. Peloquin, Gustavo E. Velásquez, Leonid Lecca et al. · Antimicrobial Agents and Chemotherapy · 2017 · 43 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +11

Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs

Helena Huerga, Uzma Khan, Mathieu Bastard et al. · Clinical Infectious Diseases · 2022 · 37 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial

M. Milstein, Leonid Lecca, Charles A. Peloquin et al. · BMC Infectious Diseases · 2016 · 32 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +13